Beam Therapeutics Inc.
BEAMNasdaqCIK 1745999HealthcareFiscal year ends Dec 31
Reports and events: 108 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0411:13 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-331541 |
| 2026-08-0411:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331522 |
| 2026-06-0820:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-261693 |
| 2026-05-0711:22 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-210338 |
| 2026-05-0711:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210299 |
| 2026-04-1720:05 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001193125-26-161512 |
| 2026-03-0521:05 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-26-093914 |
| 2026-02-2412:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-065194 |
| 2026-02-2412:05 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-065191 |
| 2026-02-1221:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-048684 |
| 2026-02-0521:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-039365 |
| 2026-01-1212:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009722 |
| 2025-12-1121:30 ET | 8-K | 2.01 Completion of an acquisition or disposition | 0001193125-25-316043 |
| 2025-11-0412:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-263542 |
| 2025-11-0412:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263536 |
| 2025-08-0511:14 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-102393 |
| 2025-08-0511:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102389 |
| 2025-07-0320:30 ET | 8-K | 3.02 Unregistered sale of equity | 0000950170-25-093906 |
| 2025-06-0620:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-083043 |
| 2025-05-0611:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-063966 |
| 2025-05-0611:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063955 |
| 2025-04-1820:00 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0000950170-25-055853 |
| 2025-03-1021:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-051072 |
| 2025-03-1010:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-050334 |
| 2025-02-2512:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-026076 |
| 2025-02-2512:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-026070 |
| 2025-01-1312:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-004558 |
| 2024-12-0912:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-272860 |
| 2024-12-0612:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-271965 |
| 2024-12-0412:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-270314 |
| 2024-11-0514:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-121104 |
| 2024-11-0514:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-121099 |
| 2024-11-0513:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-121088 |
| 2024-11-0512:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-121069 |
| 2024-08-0612:55 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091242 |
| 2024-08-0611:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091201 |
| 2024-07-1511:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-178824 |
| 2024-06-1020:30 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-071345 |
| 2024-05-0711:19 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-053939 |
| 2024-05-0711:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053928 |
| 2024-04-1920:15 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0000950170-24-046017 |
| 2024-02-2712:22 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-020622 |
| 2024-02-2711:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-020608 |
| 2024-01-0811:55 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-002673 |
| 2023-12-1421:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-295457 |
| 2023-11-0812:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-060683 |
| 2023-11-0812:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060660 |
| 2023-10-3110:44 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-056542 |
| 2023-10-1912:50 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-258963 |
| 2023-08-0811:30 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039364 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.